Most providers in the research space function as secondary resellers, sourcing through broad international trade networks where oversight is diluted across multiple handlers. At Ironview Compounds, we have eliminated these traditional layers. We maintain a direct line of communication with our dedicated synthesis facility, the very point where our peptides are created from scratch. By ensuring a Direct Chain-of-Custody, we verify the molecular integrity of our product at the source, ensuring that your research utilizes first-generation synthesis rather than aged or multi-handled inventory.